Literature DB >> 526394

Labetalol in the treatment of a patient with phaechromocytoma: a case report.

R R Bailey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 526394      PMCID: PMC1429756     

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  1 in total

1.  Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.

Authors:  E A Rosei; J J Brown; A F Lever; A S Robertson; J I Robertson; P M Trust
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

  1 in total
  6 in total

Review 1.  The management of hypertension.

Authors:  B N Prichard; C W Owens
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

2.  Labetalol in the treatment of patients with hypertension and renal function impairment.

Authors:  R R Bailey
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

Review 3.  The management of hypertensive emergencies in children after stem cell transplantation.

Authors:  D G Horn; M N Trame; G Hempel
Journal:  Int J Clin Pharm       Date:  2011-03-12

4.  The use of labetalol in Japan: results of multicentre clinical trials.

Authors:  T Takeda; Y Kaneko; T Omae; K Yoshinaga; Y Masuyama; T Nukada; R Shigiya
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

5.  Phaeochromocytoma--investigation and management of 10 cases.

Authors:  J E Deal; P S Sever; T M Barratt; M J Dillon
Journal:  Arch Dis Child       Date:  1990-03       Impact factor: 3.791

Review 6.  Combined alpha- and beta-receptor inhibition in the treatment of hypertension.

Authors:  B N Prichard
Journal:  Drugs       Date:  1984       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.